HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 75 filers reported holding HOOKIPA PHARMA INC in Q1 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46 | -29.2% | 74 | 0.0% | 0.00% | – |
| Q2 2023 | $65 | +20.4% | 74 | 0.0% | 0.00% | – |
| Q1 2023 | $54 | -10.0% | 74 | 0.0% | 0.00% | – |
| Q4 2022 | $60 | – | 74 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 74 | -71.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 261 | -68.1% | 0.00% | – |
| Q1 2022 | $2,000 | -83.3% | 819 | -83.5% | 0.00% | – |
| Q4 2021 | $12,000 | -86.4% | 4,968 | -66.8% | 0.00% | – |
| Q3 2021 | $88,000 | -40.1% | 14,950 | -6.8% | 0.00% | – |
| Q2 2021 | $147,000 | +880.0% | 16,047 | +1293.0% | 0.00% | – |
| Q1 2021 | $15,000 | -42.3% | 1,152 | -50.7% | 0.00% | – |
| Q4 2020 | $26,000 | +136.4% | 2,335 | +94.9% | 0.00% | – |
| Q3 2020 | $11,000 | -56.0% | 1,198 | -43.5% | 0.00% | – |
| Q2 2020 | $25,000 | -30.6% | 2,119 | -51.4% | 0.00% | – |
| Q1 2020 | $36,000 | +50.0% | 4,360 | +118.1% | 0.00% | – |
| Q4 2019 | $24,000 | – | 1,999 | +1899.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 100 | -82.8% | 0.00% | – |
| Q2 2019 | $4,000 | – | 583 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
| Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
| Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
| HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
| DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
| Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
| HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
| Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |